Skye Bioscience Inc (SKYE)

[Vinpat]

Nobody has really come up with an effective cannabinoid drug that meets FDA standards so it's very risky until someone does. Nemus should have enough money now to get into Phase II and if they have positive results, the share price will move up and the pool of potential investors will as well. It's hard to raise big money with an OTC company and especially in this sector.

You're just not going to get this group to pump the stock like all the others do InMed is spending quite a bit on promotion. I can see the argument for it as it relates to share price but it's a bit slimy. All you're going to get here are press releases and no leaks.